StockDriftsStockDriftsTop 10 Omega Fund Management LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | 29.16% | 2.39M | $47.6M | +8.50%(+187.50K) | $24.91(+16.41%) | 2026-03-31 | |
| NUVB | Nuvation Bio Inc. | 21.25% | 8.08M | $34.7M | +0.00%(+0) | $11.07(-48.53%) | 2026-03-31 | |
| BBOT | BridgeBio Oncology Therapeutics Inc. | 18.05% | 3.29M | $29.4M | +0.00%(+0) | $11.10(-26.94%) | 2026-03-31 | |
| KMTS | Kestra Med Technologies Ltd | 12.49% | 1.02M | $20.4M | -25.59%(-351.44K) | $24.92(+8.27%) | 2026-03-31 | |
| BBNX | Beta Bionics Inc. | 8.08% | 1.32M | $13.2M | +0.00%(+0) | $12.24(+36.93%) | 2026-03-31 | |
| ENGN | enGene Holdings Inc. | 3.66% | 876.4K | $6.0M | +0.00%(+0) | $9.45(-81.17%) | 2026-03-31 | |
| ALMS | Alumis Inc. | 3.26% | 241.3K | $5.3M | -63.07%(-411.97K) | $13.30(+99.25%) | 2026-03-31 | |
| SANA | Sana Biotechnology, Inc. | 1.49% | 843.8K | $2.4M | +0.00%(+0) | $33.47(-88.02%) | 2026-03-31 | |
| IMA | ImageneBio, Inc. | 1.4% | 455.4K | $2.3M | +0.00%(+0) | $72.97(-92.01%) | 2026-03-31 | |
| REPL | Replimune Group | 1.17% | 248.7K | $1.9M | +0.00%(+0) | $16.03(-27.74%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | -32.84% | -69.70% |
| Top 20 Holdings Unweighted | -22.32% | -53.13% |
Sign up free to track Omega Fund Management LLC, compare funds side by side, and get alerts the moment positions change.